SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

MAZZADI, Alejandro; PAOLINO, Melisa  y  ARROSSI, Silvina. Aceptabilidad y conocimientos sobre la vacunación contra el virus del papiloma humano (VPH) en médicos ginecólogos de la Argentina. Salud pública Méx [online]. 2012, vol.54, n.5, pp. 515-522. ISSN 0036-3634.

    1. Harper DM. Prevention of Human Papillomavirus Infections and Associated Diseases by Vaccination: A New Hope for Global Public Health. Public Health Genomics 2009;12:319-330. [ Links ]

    2. Villa LL, Perez G, Kjaer SK, Paavonen J, Lehtinen M, Munoz N, et al. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-1927. [ Links ]

    3. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007;23:213-227. [ Links ]

    4. Ministerio de Salud. Programa Nacional de Prevención de Cáncer Cérvico-uterino. Argentina. [Consultado agosto 2011] Disponible en: http://www.msal.gov.ar/cancer-cervico-uterino/ [ Links ]

    5. Argentina. Presidencia de la Nación, Boletín Oficial de la República Argentina. Resolución 563/2011. Año CXIX, Nº 32149, 13 de mayo de 2011. [Consultado agosto 2011]. Disponible en: http://www.boletinoficial.gov.ar/DisplayPdf.aspx?s=BPBCF&f=20110513. [ Links ]

    6. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-1493. [ Links ]

    7.Reiter PL, Brewer NT, Gottlieb SL, Mcree AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009;69:475-480. [ Links ]

    8. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine 2011;29:890-895. [ Links ]

    9. Lipcovich P. Vacuna, campaña, polémica. Página 12 2008 octubre 25; sección Sociedad. [Consultado septiembre 2011]. Disponible en: http://www.pagina12.com.ar/diario/sociedad/3-113945-2008-10-25.html. [ Links ]

    10.Raley JC, Followwill KA, Zimet GD, Ault KA. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004;12:127-133. [ Links ]

    11.Leddy MA, Anderson BL, Gall S, Schulkin J. Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009;22:239-246. [ Links ]

    12.Krupp K, Marlow LA, Kielmann K, Doddaiah N, Mysore S, Reingold AL, et al. Factors associated with intention-to-recommend human papillo-mavirus vaccination among physicians in Mysore, India. J Adolesc Health 2010;46:379-384. [ Links ]

    13.Askelson NM, Campo S, Lowe JB, Dennis LK, Smith S, Andsager J. Factors related to physicians' willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioral control. Women Health 2010;50:144-158. [ Links ]

    14. Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 2010;14:339-345. [ Links ]

    15. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-433. [ Links ]

    16. Arrossi S, Maceira V, Paolino M, Sankaranarayanan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: A population-based survey. Vaccine 2012; 30:2467-2474. [ Links ]

    17. De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine 2010;28:6247-6255. [ Links ]

    18. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-314. [ Links ]

    19. Ali SF, Ayub S, Manzoor NF, Azim S, Afif M, Akhtar N, et al. Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in Tertiary Care Hospitals in Karachi, Pakistan. PLoS One 2010; 5:e11059. [ Links ]

    20. Arillo-Santillán E, Lazcano-Ponce E, Peris M, Salazar-Martínez E, Salmerón-Castro J, Alonso-De Ruiz P. El conocimiento de profesionales de la salud sobre la prevención del cáncer cervical. Alternativas de educación médica. Salud Publica Mex 2000; 42:34-42. [ Links ]

    21. Aldrich T, Becker D, García SG. Mexican physicians' knowledge and attitudes about the human papillomavirus and cervical cancer: a national survey. Sex Transm Infect 2005;81:135-141. [ Links ]

    22. Nganwai P, Truadpon P, Inpa C, Sangpetngam B, Mekjarasnapa M, Apirakarn M, et al. Knowledge, attitudes and practices visa-vis cervical cancer among registered nurses at the Faculty of medicine, Khon Kaen University, Thailand. Asian Pac J Cancer Prev 2008;9:15-18. [ Links ]

    23. Herrero R, Ferreccio C, Salmerón J, Almonte M, Sánchez GI, Lazcano-Ponce E, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26S:L49-L58. [ Links ]

    24. Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008;100:513-517. [ Links ]

    25. Cuzick J, Harbin M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand ME, et al. Overview of Human Papillomavirus-Based and Other Novel Options for Cervival Cancer Screening in Developed and Developing Countries. Vaccine 2008;K29-K41. [ Links ]

    26. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV Screening for cervical cancer in Rural India. N Engl J Med 2009;360:1385-1394. [ Links ]

    27. Solomon D, Papillo J, Davis-Davey D. Cytopathology Education and Technology Consortium Statement on HPV DNA test utilization. J Low Genit Tract Dis 2009;13:135-136. [ Links ]

    28. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004;364:1678-1683. [ Links ]

    29. Arbyn M, Kyrgiou M, Raifu AO, Koliopoulos G, Martin-Hirch P, Pren-diville W, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337: a1284. [ Links ]